Sign Up Today and Learn More About OpenEvidence Stock
Invest in or calculate the value of your shares in OpenEvidence or other pre-IPO companies through EquityZen's platform.
OpenEvidence Stock (OPEV)
OpenEvidence is a common problem in many high-value domains. It's a huge challenge in medicine.
About OpenEvidence Stock
Founded
2021
Headquarters
Cambridge, MA, US
Total Funding
476M
Industries
Software, Data and Analytics, Science and Engineering
OpenEvidence provides a proprietary AI platform for life sciences companies. Founded by individuals from Harvard and MIT, the company's service synthesizes data from scientific sources, including medical literature and clinical trials, to support functions like R&D and medical affairs. The stated mission of the company is to accelerate the translation of scientific discovery into medical practice.
OpenEvidence Press Mentions
Stay in the know about the latest news on OpenEvidence
OpenEvidence adds AI coding suggestions
techtarget • Mar 28, 2026
OpenEvidence launches Coding Intelligence™ to help physicians capture every dollar they've earned
prnewswire • Mar 26, 2026
Why OpenClaw agents are the next big enterprise challenge
computerweekly • Mar 25, 2026
AI Tool Launches Hit Record Pace as Industry Moves From Experimentation to Infrastructure
einpresswire • Mar 17, 2026
The Rising Investors Behind The New Unicorn Class
news • Mar 17, 2026
Join now and verify your accreditation status to gain access to:
- OpenEvidence Current Valuation
- OpenEvidence Stock Price
- OpenEvidence Management
- Available deals in OpenEvidence and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- OpenEvidence Cap Table and Funding History by Share Class and Liquidity Preferences
- OpenEvidence Revenue and Financials
- OpenEvidence Highlights
- OpenEvidence Business Model
- OpenEvidence Risk Factors
- OpenEvidence Research Report from SACRA Research
Trading OpenEvidence Stock
How to invest in OpenEvidence stock?
Accredited investors can buy pre-IPO stock in companies like OpenEvidence through EquityZen funds. These investments are made available by existing OpenEvidence shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell OpenEvidence stock?
Shareholders can sell their OpenEvidence stock through EquityZen's private company marketplace. EquityZen's network includes over 440K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 52K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
